016-8008765
KPJ Johor Specialist Hospital (JSH)
The yearly interventional cardiology event ENCORE Seoul was a very successful event in Korea!
Due to unforeseen circumstances, I could not attend as physical delegate and have to present my case as online delegate.
Was happy to able to share my case from IJN to the world of cardiology in Korea!
Hope for to come in future & I’m looking forward to TCTAP 2023!
Boston Scientific organized a bifurcation workshop for cardiology fellows around Malaysia.
It was held at EQ Hotel Kuala Lumpur on 15 April 2023, chaired by Datuk Dr Kumara (IJN) with Dr Choo Gim Hooi (CVSKL), Dr Jayakhantan (IJN) & Dr Dhamaraj (Hospital Alor Setar).
It was a very well organized workshop to learn how to deal with bifurcation lesion, from provisional stenting to DK Crush technique.
Learnt a lot from this wonderful workshop, definitely hope for more in future!
10 August 2022 was the day I went live on IJN Facebook page to talk about stress test or EST or treadmill test.
The above video was from IJN Official Facebook page.
In this video, I talked about what is EST, who should do it, how to do it, any alternative and the goods/bads about EST.
It was a great Friday night out with a group of doctors from MediPulse and meeting new friends from AstraZeneca.
Topic was on how to protect cardiorenal beyong HbA1c in a diabetic patient and followed by the importance on treating early high cholesterol patient.
Forxiga is a brand name for the medication dapagliflozin, which belongs to a class of drugs called sodium-glucose co-transporter 2 (SGLT2) inhibitors. Forxiga is used to treat type 2 diabetes by lowering blood sugar levels. It works by blocking the SGLT2 protein in the kidneys, which reduces the reabsorption of glucose from the kidneys and leads to increased excretion of glucose in the urine.
Forxiga is usually taken orally as a tablet once a day. It may be prescribed alone or in combination with other diabetes medications, such as metformin or insulin. Forxiga is not recommended for people with type 1 diabetes or diabetic ketoacidosis.
Great interactions with the friendly doctors from MediPulse & managers from AZ.
Crestor is a brand name for the medication rosuvastatin, which belongs to a class of drugs called statins. It is used to lower high levels of cholesterol and triglycerides in the blood, which can reduce the risk of heart attack, stroke, and other cardiovascular diseases.
Crestor works by blocking an enzyme called HMG-CoA reductase, which is involved in the production of cholesterol in the liver. By reducing the production of cholesterol, Crestor helps to decrease the amount of LDL (“bad”) cholesterol in the blood, while increasing the levels of HDL (“good”) cholesterol.
Crestor is usually taken orally as a tablet once a day, with or without food.
Great place, great friends, great food!
Special thanks to Terumo Malaysia & Ikhlas Malaysia for organizing this hands-on bailout session at IJN for cardiology department! “IJN-TERUMO Hands-On Training: Bailout Solutions”
It was a great session chaired by Datuk Dr Shaiful & Datuk Dr Kumara.
Around 20 participants for this half day workshop at IJN, guiding us step-by-step on how to manage trapped wire and vessel perforations.
We do not see much such complications in our day to day practice. Hence, such a workshop will be very valuable in our training.
With Datuk Dr Shaiful & Datuk Dr Kumara
Playing with the RM40k model!
What is a trapped wire?
“During a coronary angiogram, a thin, flexible wire called a guide wire is inserted into an artery in the wrist or groin and threaded through the blood vessels to the heart. The guide wire helps the doctor to position the catheter, which is a longer and flexible tube that is advanced over the wire to the heart’s arteries.
Sometimes during the procedure, the guide wire may become “trapped” in the arteries. This means that the wire is unable to be removed easily or smoothly, and it may require additional procedures or techniques to remove it. Trapped wires during a coronary angiogram are uncommon, but they can occur due to various reasons, including the vessel’s tortuosity, a narrow or tight artery, or a malfunctioning of the equipment used in the procedure. Prompt action by the medical team is necessary to address the situation to avoid potential complications.”
Quantitative Flow Ratio (QFR) is a non-invasive diagnostic tool that uses advanced computational algorithms to assess blood flow in the coronary arteries. QFR provides a functional assessment of the coronary arteries, allowing doctors to accurately identify significant narrowing or blockages in the arteries.
Traditional diagnostic methods for coronary artery disease, such as angiography, are invasive and require the use of contrast dye. QFR, on the other hand, uses only a routine angiogram to create a 3D model of the coronary arteries. The model is then analyzed using specialized software to determine the blood flow in each segment of the artery.
QFR works by simulating blood flow in the coronary arteries under various physiological conditions. By analyzing the flow parameters, the software can identify areas of the artery that may be significantly narrowed or blocked. This information can help doctors determine the best course of treatment for patients with coronary artery disease.
One of the benefits of QFR is that it provides accurate and reliable results with a high level of precision. Studies have shown that QFR is as effective as invasive methods such as fractional flow reserve (FFR) in assessing coronary artery disease.
Another advantage of QFR is that it is a non-invasive procedure, which means that it does not require the use of contrast dye or any other invasive techniques. This makes QFR a safer and more convenient option for patients, as there is no risk of complications or side effects associated with invasive procedures.
Overall, QFR is a promising diagnostic tool that can help doctors accurately assess blood flow in the coronary arteries and identify significant narrowing or blockages. With its high level of precision and non-invasive nature, QFR is becoming an increasingly popular option for patients with suspected coronary artery disease.
Special thanks to Biotronik for organizing this wonderful 3 days 2 nights DCB Pantera Lux workshop at Sarawak Heart Center (SHC), Kuching.
Great learning experience from the consultants at SHC regarding DCB with their case sharing!
Great to see old friends/ lecturers from UNIMAS
7 to 8 February 2023
